ADTX
Aditxt, Inc.
OTC Pharmaceutical Preparations Non-accelerated filer
Smaller reporting company

Key Financials

Revenue
$3195
↓ 97.6%
Net Income
$-43101451
↓ 6.8%
Operating Income
$-19570724
↑ 29.8%
EPS (Diluted)
$-1153.83
↑ 62.3%
Gross Profit
$268
↑ 100.1%
Total Assets
$16.5M
↓ 48.6%
Shareholders' Equity
$5.6M
↑ 1029.7%
Cash & Equivalents
$833031.00
↑ 757.9%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 7/2/2026 View on SEC
SCHEDULE 13G 7/2/2026 View on SEC
SCHEDULE 13G 6/26/2026 View on SEC
4 6/25/2026 View on SEC
SCHEDULE 13D/A 6/25/2026 View on SEC
4 6/24/2026 View on SEC
3 6/24/2026 View on SEC
4 6/24/2026 View on SEC
SCHEDULE 13G/A 6/24/2026 View on SEC
SCHEDULE 13G/A 6/24/2026 View on SEC

Company Information

Field Value
Ticker ADTX
Company Name Aditxt, Inc.
CIK 1726711
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Smaller reporting company
Exchange OTC
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 909-488-0844